Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-667
Closed -$220K 398
2025
Q2
$220K Sell
667
-40
-6% -$12.9K ﹤0.01% 365
2025
Q1
$233K Buy
+707
New +$213K ﹤0.01% 365
2024
Q4
Sell
-707
Closed -$245K 382
2024
Q3
$245K Hold
707
﹤0.01% 360
2024
Q2
$234K Hold
707
﹤0.01% 361
2024
Q1
$257K Hold
707
﹤0.01% 353
2023
Q4
$212K Buy
+707
New +$207K ﹤0.01% 366
2023
Q1
Sell
-735
Closed -$244K 367
2022
Q4
$244K Hold
735
﹤0.01% 351
2022
Q3
$204K Buy
+735
New +$207K ﹤0.01% 351

Other funds holding CI

Boston Trust Walden's CI Position: Q3 2025 in Review

Boston Trust Walden sold out of Cigna (CI) in Q3 2025, closing a stake of 667 shares — an estimated $220K sold.

Boston Trust Walden first reported a position in CI in Q3 2022 and held it in 8 quarters. The position peaked at $257K in Q1 2024. 1,618 funds tracked by Wall St. Rank hold CI as of Q3 2025.

  • Boston Trust Walden reported no remaining Cigna position as of Q3 2025 after selling out during the quarter.
  • Boston Trust Walden sold 667 Cigna shares in Q3 2025, an estimated $220K.
  • Boston Trust Walden first reported a position in Cigna in Q3 2022 and held it in 8 quarters.
  • Boston Trust Walden's Cigna position peaked at $257K in Q1 2024.
  • 1,618 funds tracked by Wall St. Rank held Cigna as of Q3 2025.

Based on Boston Trust Walden's 13F filing for Q3 2025, filed 17 Oct 2025.